Cargando…
Hepatocyte Growth Factor (HGF) Inhibits Collagen I and IV Synthesis in Hepatic Stellate Cells by miRNA-29 Induction
BACKGROUND: In chronic liver disease, hepatic stellate cells (HSC) transdifferentiate into myofibroblasts, promoting extracellular matrix (ECM) synthesis and deposition. Stimulation of HSC by transforming growth factor-β (TGF-β) is a crucial event in liver fibrogenesis due to its impact on myofibrob...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170366/ https://www.ncbi.nlm.nih.gov/pubmed/21931759 http://dx.doi.org/10.1371/journal.pone.0024568 |
_version_ | 1782211621509136384 |
---|---|
author | Kwiecinski, Monika Noetel, Andrea Elfimova, Natalia Trebicka, Jonel Schievenbusch, Stephanie Strack, Ingo Molnar, Levente von Brandenstein, Melanie Töx, Ulrich Nischt, Roswitha Coutelle, Oliver Dienes, Hans Peter Odenthal, Margarete |
author_facet | Kwiecinski, Monika Noetel, Andrea Elfimova, Natalia Trebicka, Jonel Schievenbusch, Stephanie Strack, Ingo Molnar, Levente von Brandenstein, Melanie Töx, Ulrich Nischt, Roswitha Coutelle, Oliver Dienes, Hans Peter Odenthal, Margarete |
author_sort | Kwiecinski, Monika |
collection | PubMed |
description | BACKGROUND: In chronic liver disease, hepatic stellate cells (HSC) transdifferentiate into myofibroblasts, promoting extracellular matrix (ECM) synthesis and deposition. Stimulation of HSC by transforming growth factor-β (TGF-β) is a crucial event in liver fibrogenesis due to its impact on myofibroblastic transition and ECM induction. In contrast, hepatocyte growth factor (HGF), exerts antifibrotic activities. Recently, miR-29 has been reported to be involved in ECM synthesis. We therefore studied the influence of HGF and TGF-β on the miR-29 collagen axis in HSC. METHODOLOGY: HSC, isolated from rats, were characterized for HGF and Met receptor expression by Real-Time PCR and Western blotting during culture induced myofibroblastic transition. Then, the levels of TGF-β, HGF, collagen-I and -IV mRNA, in addition to miR-29a and miR-29b were determined after HGF and TGF-β stimulation of HSC or after experimental fibrosis induced by bile-duct obstruction in rats. The interaction of miR-29 with 3′-untranslated mRNA regions (UTR) was analyzed by reporter assays. The repressive effect of miR-29 on collagen synthesis was studied in HSC treated with miR-29-mimicks by Real-Time PCR and immunoblotting. PRINCIPAL FINDINGS: The 3′-UTR of the collagen-1 and −4 subtypes were identified to bind miR-29. Hence, miR-29a/b overexpression in HSC resulted in a marked reduction of collagen-I and -IV synthesis. Conversely, a decrease in miR-29 levels is observed during collagen accumulation upon experimental fibrosis, in vivo, and after TGF-β stimulation of HSC, in vitro. Finally, we show that during myofibroblastic transition and TGF-β exposure the HGF-receptor, Met, is upregulated in HSC. Thus, whereas TGF-β stimulation leads to a reduction in miR-29 expression and de-repression of collagen synthesis, stimulation with HGF was definitely associated with highly elevated miR-29 levels and markedly repressed collagen-I and -IV synthesis. CONCLUSIONS: Upregulation of miRNA-29 by HGF and downregulation by TGF-β take part in the anti- or profibrogenic response of HSC, respectively. |
format | Online Article Text |
id | pubmed-3170366 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-31703662011-09-19 Hepatocyte Growth Factor (HGF) Inhibits Collagen I and IV Synthesis in Hepatic Stellate Cells by miRNA-29 Induction Kwiecinski, Monika Noetel, Andrea Elfimova, Natalia Trebicka, Jonel Schievenbusch, Stephanie Strack, Ingo Molnar, Levente von Brandenstein, Melanie Töx, Ulrich Nischt, Roswitha Coutelle, Oliver Dienes, Hans Peter Odenthal, Margarete PLoS One Research Article BACKGROUND: In chronic liver disease, hepatic stellate cells (HSC) transdifferentiate into myofibroblasts, promoting extracellular matrix (ECM) synthesis and deposition. Stimulation of HSC by transforming growth factor-β (TGF-β) is a crucial event in liver fibrogenesis due to its impact on myofibroblastic transition and ECM induction. In contrast, hepatocyte growth factor (HGF), exerts antifibrotic activities. Recently, miR-29 has been reported to be involved in ECM synthesis. We therefore studied the influence of HGF and TGF-β on the miR-29 collagen axis in HSC. METHODOLOGY: HSC, isolated from rats, were characterized for HGF and Met receptor expression by Real-Time PCR and Western blotting during culture induced myofibroblastic transition. Then, the levels of TGF-β, HGF, collagen-I and -IV mRNA, in addition to miR-29a and miR-29b were determined after HGF and TGF-β stimulation of HSC or after experimental fibrosis induced by bile-duct obstruction in rats. The interaction of miR-29 with 3′-untranslated mRNA regions (UTR) was analyzed by reporter assays. The repressive effect of miR-29 on collagen synthesis was studied in HSC treated with miR-29-mimicks by Real-Time PCR and immunoblotting. PRINCIPAL FINDINGS: The 3′-UTR of the collagen-1 and −4 subtypes were identified to bind miR-29. Hence, miR-29a/b overexpression in HSC resulted in a marked reduction of collagen-I and -IV synthesis. Conversely, a decrease in miR-29 levels is observed during collagen accumulation upon experimental fibrosis, in vivo, and after TGF-β stimulation of HSC, in vitro. Finally, we show that during myofibroblastic transition and TGF-β exposure the HGF-receptor, Met, is upregulated in HSC. Thus, whereas TGF-β stimulation leads to a reduction in miR-29 expression and de-repression of collagen synthesis, stimulation with HGF was definitely associated with highly elevated miR-29 levels and markedly repressed collagen-I and -IV synthesis. CONCLUSIONS: Upregulation of miRNA-29 by HGF and downregulation by TGF-β take part in the anti- or profibrogenic response of HSC, respectively. Public Library of Science 2011-09-09 /pmc/articles/PMC3170366/ /pubmed/21931759 http://dx.doi.org/10.1371/journal.pone.0024568 Text en Kwiecinski et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Kwiecinski, Monika Noetel, Andrea Elfimova, Natalia Trebicka, Jonel Schievenbusch, Stephanie Strack, Ingo Molnar, Levente von Brandenstein, Melanie Töx, Ulrich Nischt, Roswitha Coutelle, Oliver Dienes, Hans Peter Odenthal, Margarete Hepatocyte Growth Factor (HGF) Inhibits Collagen I and IV Synthesis in Hepatic Stellate Cells by miRNA-29 Induction |
title | Hepatocyte Growth Factor (HGF) Inhibits Collagen I and IV Synthesis in Hepatic Stellate Cells by miRNA-29 Induction |
title_full | Hepatocyte Growth Factor (HGF) Inhibits Collagen I and IV Synthesis in Hepatic Stellate Cells by miRNA-29 Induction |
title_fullStr | Hepatocyte Growth Factor (HGF) Inhibits Collagen I and IV Synthesis in Hepatic Stellate Cells by miRNA-29 Induction |
title_full_unstemmed | Hepatocyte Growth Factor (HGF) Inhibits Collagen I and IV Synthesis in Hepatic Stellate Cells by miRNA-29 Induction |
title_short | Hepatocyte Growth Factor (HGF) Inhibits Collagen I and IV Synthesis in Hepatic Stellate Cells by miRNA-29 Induction |
title_sort | hepatocyte growth factor (hgf) inhibits collagen i and iv synthesis in hepatic stellate cells by mirna-29 induction |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170366/ https://www.ncbi.nlm.nih.gov/pubmed/21931759 http://dx.doi.org/10.1371/journal.pone.0024568 |
work_keys_str_mv | AT kwiecinskimonika hepatocytegrowthfactorhgfinhibitscollageniandivsynthesisinhepaticstellatecellsbymirna29induction AT noetelandrea hepatocytegrowthfactorhgfinhibitscollageniandivsynthesisinhepaticstellatecellsbymirna29induction AT elfimovanatalia hepatocytegrowthfactorhgfinhibitscollageniandivsynthesisinhepaticstellatecellsbymirna29induction AT trebickajonel hepatocytegrowthfactorhgfinhibitscollageniandivsynthesisinhepaticstellatecellsbymirna29induction AT schievenbuschstephanie hepatocytegrowthfactorhgfinhibitscollageniandivsynthesisinhepaticstellatecellsbymirna29induction AT strackingo hepatocytegrowthfactorhgfinhibitscollageniandivsynthesisinhepaticstellatecellsbymirna29induction AT molnarlevente hepatocytegrowthfactorhgfinhibitscollageniandivsynthesisinhepaticstellatecellsbymirna29induction AT vonbrandensteinmelanie hepatocytegrowthfactorhgfinhibitscollageniandivsynthesisinhepaticstellatecellsbymirna29induction AT toxulrich hepatocytegrowthfactorhgfinhibitscollageniandivsynthesisinhepaticstellatecellsbymirna29induction AT nischtroswitha hepatocytegrowthfactorhgfinhibitscollageniandivsynthesisinhepaticstellatecellsbymirna29induction AT coutelleoliver hepatocytegrowthfactorhgfinhibitscollageniandivsynthesisinhepaticstellatecellsbymirna29induction AT dieneshanspeter hepatocytegrowthfactorhgfinhibitscollageniandivsynthesisinhepaticstellatecellsbymirna29induction AT odenthalmargarete hepatocytegrowthfactorhgfinhibitscollageniandivsynthesisinhepaticstellatecellsbymirna29induction |